Bill
Bill > A653
summary
Introduced
01/14/2020
01/14/2020
In Committee
01/14/2020
01/14/2020
Crossed Over
Passed
Dead
01/11/2022
01/11/2022
Introduced Session
2020-2021 Regular Session
Bill Summary
This bill provides that carriers that provide coverage for prescription drugs pursuant to the terms of a health benefits plan offered by the carrier are prohibited from requiring a covered person to pay, for a covered prescription insulin drug, an amount exceeding $100 per 30 day supply of insulin, regardless of the amount or type of insulin needed to fill the covered person's prescription. Places cap of $100 on amount paid by covered persons for purchase of insulin.
AI Summary
This bill places a cap of $100 on the amount that covered persons must pay for a 30-day supply of prescription insulin drugs, regardless of the type or amount of insulin needed. It prohibits insurance carriers from requiring a covered person to pay more than $100 per 30-day supply, although carriers are allowed to reduce the cost-sharing amount even further. The bill defines "prescription insulin drug" to include various articles containing insulin used to treat diabetes, but excludes biological products, devices, and their components. The bill will take effect on the first day of the seventh month following its enactment, and the Commissioner of Banking and Insurance can take necessary administrative actions in advance of the effective date.
Committee Categories
Business and Industry
Sponsors (4)
Last Action
Combined with A954/1669 (ACS) (on 02/13/2020)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| BillText | https://www.njleg.state.nj.us/2020/Bills/A1000/653_I1.HTM |
| Bill | https://www.njleg.state.nj.us/2020/Bills/A1000/653_I1.PDF |
Loading...